The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Open accessAbstract
The Coronavirus Disease 2019 (COVID-19) has already caused hundreds of thousands of deaths worldwide in a few months. Cardiovascular disease, hypertension, diabetes and chronic lung disease have been identified as the main COVID-19 comorbidities. Moreover, despite similar infection rates between men and women, the most severe course of the disease is higher in elderly and co-morbid male patients. Therefore, the occurrence of specific comorbidities associated with renin-angiotensin system (RAS) imbalance mediated by the interaction between angiotensin-converting enzyme 2 (ACE2) and desintegrin and metalloproteinase domain 17 (ADAM17), along with specific genetic factors mainly associated with type II transmembrane serine protease (TMPRSS2) expression, could be decisive for the clinical outcome of COVID-19. Indeed, the exacerbated ADAM17-mediated ACE2, TNF-α, and IL-6R secretion emerges as a possible underlying mechanism for the acute inflammatory immune response and the activation of the coagulation cascade. Therefore, in this review, we focus on the main pathophysiological aspects of ACE2, ADAM17, and TMPRSS2 host proteins in COVID-19. Additionally, we discuss a possible mechanism to explain the deleterious effect of ADAM17 and TMPRSS2 over-activation in the COVID-19 outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“ACE2 is a type I transmembrane, endothelium-bound carboxymonopeptidase protein, and ubiquitously expressed in endothelial cells of several organs, with the highest levels in the cardiovascular system, intestine, kidneys, brain, testicles and lungs (23).”
BackgroundTang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445 · cited 4×
“Interestingly, after SARS-CoV infection of myocardial and lung tissues, the ACE2 mRNA expression is also inhibited (76, 94, 95).”
BackgroundInfluential(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.003 · Cited by 3,323
To, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
Jin, J.-M., Bai, P., He, W., Wu, F., Liu, X.-F., Han, D.-M., Liu, S., & Yang, J.-K. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00152 · Cited by 2,325
COVID-19 and African Americans
Yancy, C. W. (2020) · JAMA · doi:10.1001/jama.2020.6548 · Cited by 1,934
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Multiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · cited 2×
“ACE2, TMPRSS2, and cathepsin L are highly expressed and active in the kidney (89, 90).”
BackgroundAngiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
The COVID-19 Cytokine Storm; What We Know So Far
Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R., & Salem, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01446 · Cited by 1,622
Neutrophil extracellular traps in COVID-19
Zuo, Y., Yalavarthi, S., Shi, H., Gockman, K., Zuo, M., Madison, J. A., Blair, C. N., Weber, A., Barnes, B. J., Egeblad, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138999 · Cited by 1,582
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
COVID-19 and smoking: A systematic review of the evidence
Vardavas, C., & Nikitara, K. (2020) · Tobacco Induced Diseases · doi:10.18332/tid/119324 · Cited by 1,380
Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02232-10 · Cited by 1,108
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,052
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202001-0179le · Cited by 916 · cited 1×
“There are evidences that ACE2 activity differs between males and females (38), with males having higher levels in the lungs (39).”
BackgroundHuman kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection
Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22781-1 · Cited by 900
SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., Penninger, J. M., & Butany, J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02153.x · Cited by 893
Heurich, A., Hofmann-Winkler, H., Gierer, S., Liepold, T., Jahn, O., & Pöhlmann, S. (2014) · Journal of Virology · doi:10.1128/jvi.02202-13 · Cited by 881
Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
Channappanavar, R., Fett, C., Mack, M., Ten Eyck, P. P., Meyerholz, D. K., & Perlman, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601896 · Cited by 871
Cao, Y., Li, L., Feng, Z., Wan, S., Huang, P., Sun, X., Wen, F., Huang, X., Ning, G., & Wang, W. (2020) · Cell Discovery · doi:10.1038/s41421-020-0147-1 · Cited by 865
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Matsuyama, S., Nagata, N., Shirato, K., Kawase, M., Takeda, M., & Taguchi, F. (2010) · Journal of Virology · doi:10.1128/jvi.01542-10 · Cited by 778
Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Lian, N., Deng, Y., & Lin, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25889 · Cited by 724
Transmission potential and severity of COVID-19 in South Korea
Shim, E., Tariq, A., Choi, W., Lee, Y., & Chowell, G. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.031 · Cited by 705
Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505111200 · Cited by 694
Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S., & Gallagher, T. (2011) · Journal of Virology · doi:10.1128/jvi.02062-10 · Cited by 693
ADAM17: a molecular switch to control inflammation and tissue regeneration
Scheller, J., Chalaris, A., Garbers, C., & Rose-John, S. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.005 · Cited by 526
Haga, S., Yamamoto, N., Nakai-Murakami, C., Osawa, Y., Tokunaga, K., Sata, T., Yamamoto, N., Sasazuki, T., & Ishizaka, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711241105 · Cited by 521
Kuba, K., Imai, Y., Ohto-Nakanishi, T., & Penninger, J. M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.003 · Cited by 480
Devaux, C. A., Rolain, J.-M., & Raoult, D. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.04.015 · Cited by 476
Sama, I. E., Ravera, A., Santema, B. T., van Goor, H., ter Maaten, J. M., Cleland, J. G. F., Rienstra, M., Friedrich, A. W., Samani, N. J., Ng, L. L., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa373 · Cited by 460
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 457
The stimulation of thrombosis by hypoxia
Gupta, N., Zhao, Y.-Y., & Evans, C. E. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.07.013 · Cited by 435
Asselta, R., Paraboschi, E. M., Mantovani, A., & Duga, S. (2020) · Aging · doi:10.18632/aging.103415 · Cited by 422
Smith, J. C., Sausville, E. L., Girish, V., Yuan, M. L., Vasudevan, A., John, K. M., & Sheltzer, J. M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.012 · Cited by 415
Marshall, R. P., Webb, S., Bellingan, G. J., Montgomery, H. E., Chaudhari, B., McAnulty, R. J., Humphries, S. E., Hill, M. R., & Laurent, G. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108086 · Cited by 412
Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE
Adrain, C., Zettl, M., Christova, Y., Taylor, N., & Freeman, M. (2012) · Science · doi:10.1126/science.1214400 · Cited by 407
Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
Zou, Z., Yan, Y., Shu, Y., Gao, R., Sun, Y., Li, X., Ju, X., Liang, Z., Liu, Q., Zhao, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4594 · Cited by 401
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103474 · Cited by 395
Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
Li, Y., Zhou, W., Yang, L., & You, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104833 · Cited by 378
ADAM-17: the enzyme that does it all
Gooz, M. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409231003628015 · Cited by 377
Chalaris, A., Rabe, B., Paliga, K., Lange, H., Laskay, T., Fielding, C. A., Jones, S. A., Rose-John, S., & Scheller, J. (2007) · Blood · doi:10.1182/blood-2007-01-067918 · Cited by 329
Patel, V. B., Clarke, N., Wang, Z., Fan, D., Parajuli, N., Basu, R., Putko, B., Kassiri, Z., Turner, A. J., & Oudit, G. Y. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.017 · Cited by 321
Saheb Sharif-Askari, N., Saheb Sharif-Askari, F., Alabed, M., Temsah, M.-H., Al Heialy, S., Hamid, Q., & Halwani, R. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.013 · Cited by 317
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection
Matsuyama, S., Ujike, M., Morikawa, S., Tashiro, M., & Taguchi, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503203102 · Cited by 315
Nicotine and the renin-angiotensin system
Oakes, J. M., Fuchs, R. M., Gardner, J. D., Lazartigues, E., & Yue, X. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00099.2018 · Cited by 312
Xia, S., Lan, Q., Su, S., Wang, X., Xu, W., Liu, Z., Zhu, Y., Wang, Q., Lu, L., & Jiang, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0184-0 · Cited by 312
Horiuchi, K., Le Gall, S., Schulte, M., Yamaguchi, T., Reiss, K., Murphy, G., Toyama, Y., Hartmann, D., Saftig, P., & Blobel, C. P. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-01-0014 · Cited by 310
Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling
Loganathan, S. K., Schleicher, K., Malik, A., Quevedo, R., Langille, E., Teng, K., Oh, R. H., Rathod, B., Tsai, R., Samavarchi-Tehrani, P., et al. (2020) · Science · doi:10.1126/science.aax0902 · Cited by 283
Angiotensin Converting Enzyme 2: A Double-Edged Sword
Wang, K., Gheblawi, M., & Oudit, G. Y. (2020) · Circulation · doi:10.1161/circulationaha.120.047049 · Cited by 265
Benetti, E., Tita, R., Spiga, O., Ciolfi, A., Birolo, G., Bruselles, A., Doddato, G., Giliberti, A., Marconi, C., Musacchia, F., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0691-z · Cited by 263
Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
Epelman, S., Tang, W. H. W., Chen, S. Y., Van Lente, F., Francis, G. S., & Sen, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.088 · Cited by 250
Kuhn, J. H., Li, W., Choe, H., & Farzan, M. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-004-4242-5 · Cited by 249
Liu, J., Ji, H., Zheng, W., Wu, X., Zhu, J. J., Arnold, A. P., & Sandberg, K. (2010) · Biology of Sex Differences · doi:10.1186/2042-6410-1-6 · Cited by 246
Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
Gu, H., Xie, Z., Li, T., Zhang, S., Lai, C., Zhu, P., Wang, K., Han, L., Duan, Y., Zhao, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep19840 · Cited by 246
Alghamdi, I., Hussain, I., Alghamdi, M., Almalki, S., Alghamdi, M., & Elsheemy, M. (2014) · International Journal of General Medicine · doi:10.2147/ijgm.s67061 · Cited by 245
Cellular entry of the SARS coronavirus
Hofmann, H., & Pöhlmann, S. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.08.008 · Cited by 237
Koff, J. L., Shao, M. X. G., Ueki, I. F., & Nadel, J. A. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00025.2008 · Cited by 226
Hemnes, A. R., Rathinasabapathy, A., Austin, E. A., Brittain, E. L., Carrier, E. J., Chen, X., Fessel, J. P., Fike, C. D., Fong, P., Fortune, N., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02638-2017 · Cited by 220
Paleolithic to Bronze Age Siberians Reveal Connections with First Americans and across Eurasia
Yu, H., Spyrou, M. A., Karapetian, M., Shnaider, S., Radzevičiūtė, R., Nägele, K., Neumann, G. U., Penske, S., Zech, J., Lucas, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.037 · Cited by 216
Cell Pyroptosis, a Potential Pathogenic Mechanism of 2019-nCoV Infection
Yang, M. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3527420 · Cited by 200
Bukowska, A., Spiller, L., Wolke, C., Lendeckel, U., Weinert, S., Hoffmann, J., Bornfleth, P., Kutschka, I., Gardemann, A., Isermann, B., et al. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217718808 · Cited by 195
ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site
Le Gall, S. M., Maretzky, T., Issuree, P. D. A., Niu, X.-D., Reiss, K., Saftig, P., Khokha, R., Lundell, D., & Blobel, C. P. (2010) · Journal of Cell Science · doi:10.1242/jcs.069997 · Cited by 191
Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology
Eguchi, S., Kawai, T., Scalia, R., & Rizzo, V. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10266 · Cited by 189
Phosphatidylserine exposure is required for ADAM17 sheddase function
Sommer, A., Kordowski, F., Büch, J., Maretzky, T., Evers, A., Andrä, J., Düsterhöft, S., Michalek, M., Lorenzen, I., Somasundaram, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms11523 · Cited by 165
Federici, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26052 · Cited by 163
SARS-CoV-2 strategically mimics proteolytic activation of human ENaC
Anand, P., Puranik, A., Aravamudan, M., Venkatakrishnan, A., & Soundararajan, V. (2020) · eLife · doi:10.7554/elife.58603 · Cited by 162
ACE2 alterations in kidney disease
Soler, M. J., Wysocki, J. A., & BATLLE, D. C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft320 · Cited by 135
Age and sex differences in soluble ACE2 may give insights for COVID-19
Swärd, P., Edsfeldt, A., Reepalu, A., Jehpsson, L., Rosengren, B. E., & Karlsson, M. K. (2020) · Critical Care · doi:10.1186/s13054-020-02942-2 · Cited by 128
Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice
Salem, E., Grobe, N., & Elased, K. M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00516.2013 · Cited by 120
Sex differences in the aging pattern of renin–angiotensin system serum peptidases
Fernández‐Atutxa, A., Izagirre, A., Fraile-Bermúdez, A. B., Kortajarena, M., Larrinaga, G., Martínez‐Lage, P., Echevarría, E., & Gil, J. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0128-8 · Cited by 115
ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer
Schumacher, N., & Rose‐John, S. (2019) · Cancers · doi:10.3390/cancers11111736 · Cited by 112
Bhattacharyya, C., Das, C., Ghosh, A., Singh, A. K., Mukherjee, S., Majumder, P. P., Basu, A., & Biswas, N. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.04.075911 · Cited by 110
Renin relationship to sex, race and age in a normotensive population.
James, G. D., Sealey, J. E., Müller, F., Alderman, M. H., Madhavan, S., & LARAGH, J. H. (1986) · PubMed · Cited by 104
Luo, Y., Liu, C., Guan, T., Li, Y., Lai, Y., Li, F., Zhao, H., Maimaiti, T., & Zeyaweiding, A. (2018) · Hypertension Research · doi:10.1038/s41440-018-0166-6 · Cited by 104
Wang, X., Oka, T., Chow, F. L., Cooper, S., Odenbach, J., Lopaschuk, G. D., Kassiri, Z., & Fernández-Patrón, C. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.127670 · Cited by 96
Fiorentino, L., Vivanti, A., Cavalera, M., Marzano, V., Ronci, M., Fabrizi, M., Menini, S., Pugliese, G., Menghini, R., Khokha, R., et al. (2009) · Hepatology · doi:10.1002/hep.23250 · Cited by 93
Argañaraz, E. R., Schindler, M., Kirchhoff, F., Cortes, M. J., & Lama, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303679200 · Cited by 93
Self-citationOudit, G. Y., & Pfeffer, M. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa414 · Cited by 85
High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage
Bernardi, S., Toffoli, B., Zennaro, C., Tikellis, C., Monticone, S., Losurdo, P., Bellini, G., Thomas, M. C., Fallo, F., Veglio, F., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr600 · Cited by 81
Cell Surface CD4 Interferes with the Infectivity of HIV-1 Particles Released from T Cells
Cortés, M. J., Wong‐Staal, F., & Lama, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109807200 · Cited by 76
Satoh, M., Nakamura, M., Satoh, H., Saitoh, H., Segawa, I., & Hiramori, K. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00827-5 · Cited by 75
Luo, Y., Liu, C., Guan, T., Li, Y., Lai, Y., Li, F., Zhao, H., Maimaiti, T., & Zeyaweiding, A. (2019) · Hypertension Research · doi:10.1038/s41440-019-0205-y · Cited by 72
Regulation of urinary ACE2 in diabetic mice
Wysocki, J. A., Garcia-Halpin, L., Ye, M., Maier, C., Sowers, K. M. R., Burns, K. D., & BATLLE, D. C. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00600.2012 · Cited by 69
Satoh, M., Ishikawa, Y., Itoh, T., Minami, Y., Takahashi, Y., & Nakamura, M. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01912.x · Cited by 59
Melittin Modulates Keratinocyte Function through P2 Receptor-dependent ADAM Activation
Sommer, A., Fries, A., Cornelsen, I., Speck, N., Koch‐Nolte, F., Gimpl, G., Andrä, J., Bhakdi, S., & Reiß, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362756 · Cited by 58
Roles of Coagulation and Fibrinolysis in Angiotensin II ‐Enhanced Microvascular Thrombosis
Senchenkova, E. Y., Russell, J., Esmon, C. T., & Granger, D. N. (2014) · Microcirculation · doi:10.1111/micc.12120 · Cited by 53
Lavrentyev, E. N., & Malik, K. U. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00239.2008 · Cited by 53
Racial/Ethnic Variation in Nasal Gene Expression of Transmembrane Serine Protease 2 (TMPRSS2).
Bunyavanich, S., Grant, C., & Vicencio, A. (2020) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2020.17386 · Cited by 52
Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice
Grant, M. K. O., Seelig, D. M., Sharkey, L. C., & Zordoky, B. N. M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-016-0124-4 · Cited by 51
Loss of TIMP3 selectively exacerbates diabetic nephropathy
Basu, R., Lee, J., Wang, Z., Patel, V. B., Dong, F., Das, S. K., Liu, G. C., John, R., Scholey, J. W., Oudit, G. Y., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00349.2012 · Cited by 50
Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations
Russo, R., Andolfo, I., Lasorsa, V. A., Iolascon, A., & Capasso, M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00872 · Cited by 50
Angiotensin‐converting enzyme 2 and the kidney
Soler, M. J., Wysocki, J. A., & BATLLE, D. C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.041350 · Cited by 49
Macari, G., Toti, D., Pasquadibisceglie, A., & Polticelli, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249548 · Cited by 49
ANGIOTENSIN CONVERTING ENZYME 2 IN THE KIDNEY
Koïtka, A., Cooper, M. E., Thomas, M. C., & Tikellis, C. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04889.x · Cited by 48
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
Mascolo, A., Scavone, C., Rafaniello, C., Ferrajolo, C., Racagni, G., Berrino, L., Paolisso, G., Rossi, F., & Capuano, A. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00143 · Cited by 42
Satoh, M., Iwasaka, J., Nakamura, M., Akatsu, T., Shimoda, Y., & Hiramori, K. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.02.007 · Cited by 40
Wang, R., Ahmed, J., Wang, G., Hassan, I., Strulovici‐Barel, Y., Salit, J., Mezey, J. G., & Crystal, R. G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101895 · Cited by 38
Stolarczyk, M., Amatngalim, G. D., Yu, X., Veltman, M., Hiemstra, P. S., & Scholte, B. J. (2016) · Physiological Reports · doi:10.14814/phy2.12878 · Cited by 37
Shimoda, Y., Satoh, M., Nakamura, M., Akatsu, T., & Hiramori, K. (2005) · Clinical Science · doi:10.1042/cs20040229 · Cited by 35
Cardellini, M., Menghini, R., Luzi, A., Davato, F., Cardolini, I., D’Alfonso, R., Gentileschi, P., Rizza, S., Marini, M. A., Porzio, O., et al. (2011) · Diabetes · doi:10.2337/db11-0162 · Cited by 31
Lee, S. W., Li, Q., Libbus, I., Xie, X., KenKnight, B. H., Garry, M. G., & Tolkacheva, E. G. (2016) · Physiological Reports · doi:10.14814/phy2.12786 · Cited by 24
Do-Umehara, H. C., Chen, C., Zhang, Q., Misharin, A. V., Abdala‐Valencia, H., Casalino‐Matsuda, S. M., Reyfman, P. A., Anekalla, K. R., González-González, F. J., Sala, M. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb7238 · Cited by 24
Cited by
Chen, H., Peng, J., Wang, T., Wen, J., Chen, S., Huang, Y., & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115370 · Cited by 19
Metadata
- Authors
- Zipeto, D., Palmeira, J. D. F., Argañaraz, G. A., & Argañaraz, E. R.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-10-07
- Volume
- 11
- Pages
- 576745-576745
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3092005914
- Cited by
- 267
- References
- 120
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.